Cardinal Health Inc (NYSE:CAH) was upgraded by Evercore ISI to an “outperform” rating in a report issued on Thursday.
CAH has been the subject of a number of other reports. Mizuho lowered shares of Cardinal Health from a “buy” rating to a “neutral” rating and set a $79.00 target price for the company. in a research note on Tuesday, January 3rd. Vetr downgraded shares of Cardinal Health from a “hold” rating to a “sell” rating and set a $79.00 target price for the company. in a report on Monday, February 27th. Leerink Swann set a $81.00 target price on shares of Cardinal Health and gave the stock a “hold” rating in a report on Wednesday, February 8th. Needham & Company LLC assumed coverage on shares of Cardinal Health in a report on Tuesday, April 4th. They issued a “hold” rating for the company. Finally, Zacks Investment Research raised shares of Cardinal Health from a “sell” rating to a “hold” rating in a report on Friday, December 16th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and five have given a buy rating to the stock. Cardinal Health currently has a consensus rating of “Hold” and a consensus price target of $85.73.
Cardinal Health (NYSE:CAH) traded down 1.54% on Thursday, reaching $72.18. The company’s stock had a trading volume of 1,772,174 shares. The company has a market cap of $22.77 billion, a P/E ratio of 17.38 and a beta of 0.71. Cardinal Health has a 12 month low of $62.70 and a 12 month high of $87.33. The company has a 50-day moving average price of $81.14 and a 200 day moving average price of $75.87.
Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Tuesday, February 7th. The company reported $1.34 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.23 by $0.11. The firm had revenue of $33.10 billion for the quarter, compared to the consensus estimate of $33.63 billion. Cardinal Health had a return on equity of 25.52% and a net margin of 1.06%. The company’s quarterly revenue was up 5.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.30 earnings per share. On average, equities research analysts anticipate that Cardinal Health will post $5.41 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Saturday, April 15th. Stockholders of record on Monday, April 3rd were given a dividend of $0.4489 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.45%. The ex-dividend date of this dividend was Thursday, March 30th. Cardinal Health’s dividend payout ratio (DPR) is presently 43.17%.
TRADEMARK VIOLATION WARNING: This article was posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.chaffeybreeze.com/2017/04/21/cardinal-health-inc-cah-upgraded-to-outperform-at-evercore-isi-updated.html.
In other news, Chairman George S. Barrett sold 217,994 shares of the stock in a transaction that occurred on Friday, February 10th. The shares were sold at an average price of $77.23, for a total transaction of $16,835,676.62. Following the transaction, the chairman now directly owns 682,225 shares in the company, valued at $52,688,236.75. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.94% of the stock is currently owned by company insiders.
Several institutional investors have recently added to or reduced their stakes in the stock. Alpha Windward LLC increased its position in Cardinal Health by 0.8% in the third quarter. Alpha Windward LLC now owns 2,133 shares of the company’s stock worth $166,000 after buying an additional 16 shares in the last quarter. KCM Investment Advisors LLC increased its stake in shares of Cardinal Health by 0.3% in the third quarter. KCM Investment Advisors LLC now owns 5,778 shares of the company’s stock valued at $449,000 after buying an additional 17 shares during the period. Geneva Advisors LLC increased its stake in shares of Cardinal Health by 0.4% in the third quarter. Geneva Advisors LLC now owns 6,840 shares of the company’s stock valued at $531,000 after buying an additional 25 shares during the period. Johnson Investment Counsel Inc. increased its stake in shares of Cardinal Health by 0.4% in the third quarter. Johnson Investment Counsel Inc. now owns 8,987 shares of the company’s stock valued at $698,000 after buying an additional 34 shares during the period. Finally, Private Trust Co. NA increased its stake in shares of Cardinal Health by 0.3% in the first quarter. Private Trust Co. NA now owns 13,731 shares of the company’s stock valued at $1,119,000 after buying an additional 41 shares during the period. Hedge funds and other institutional investors own 85.84% of the company’s stock.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.